Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioThrax PEP Immunogenicity and Safety Study
NCT01491607Phase 3Completed
- Sponsor
- Emergent BioSolutions
- Start
- Nov 2011
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of anthrax vaccine adsorbed in anthrax, sponsored by Emergent BioSolutions. Started Nov 2011; status: completed.
02
Drugs
anthrax vaccine adsorbed
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT01491607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491607.